Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men

Sexually Transmitted Diseases

Volumn 40, Issue 1, 2013, Pages 3-10

  Videla, Sebastian ^a   Darwich, Laila ^b,c   Cañadas, Mari Paz ^b,d   Coll, Josep ^a,b   Piñol, Marta ^e   García Cuyás, Francesc ^e   Molina Lopez, Rafael A ^a   Cobarsi, Patricia ^a   Clotet, Bonaventura ^a,b,e   Sirera, Guillem ^a,e  

^a Lluita Contra la SIDA Foundation   (Spain)

^b IrsiCaixa Foundation   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d SYNLAB ACADEMY   (Germany)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; COURSE EVALUATION; DISEASE COURSE; HETEROSEXUAL MALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEDICAL HISTORY; MIXED INFECTION; MOUTH INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; PAPILLOMAVIRUS INFECTION; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; SEXUAL BEHAVIOR; VIRAL CLEARANCE;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ANUS DISEASES; COHORT STUDIES; FOLLOW-UP STUDIES; HETEROSEXUALITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUTH DISEASES; MULTIPLEX POLYMERASE CHAIN REACTION; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SPAIN; YOUNG ADULT;

EID: 84871577406     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31827e87bd     Document Type: Article

References (28)

1. Bosch FX, de San José S. Chapter 1: Human papillomavirus and cervical cancerVburden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13.
2. Welton ML, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 2004; 13: 263-275.
3. Dillner J, von Krogh G, Horenblas S, et al. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol 2000; 205: 189-193.
4. Aboulafia DM, Gibbons R. Penile cancer and human papillomavi-rus (HPV) in a human immunodeficiency virus (HIV)Yinfected patient. Cancer Invest 2001; 19: 266-272.
5. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131.
6. Herrero R, Castellsagué X, Pawlita M, et al. IARC Multicenter Oral Cancer Study Group. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-1783.
7. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-1510.
8. Goedert JJ, Coté TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833-1839.
9. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neopla-sia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19: 1407-1414.
10. Ostor AG. Natural history of cervical intraepithelial neoplasia: A critical review. Int J Gynecol Pathol 1993; 12: 186-192.
11. Epstein RJ. Primary prevention of human papillomavirus dependent neoplasia: No condom, no sex. Eur J Cancer 2005; 41: 2595-2600.
12. Sirera G, Videla S, Piñol M, et al. High prevalence of human papil-lomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006; 20: 1201-1204.
13. Critchlow CW, Hawes SE, Kuypers JM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 1998; 12: 1177-1184.
14. de Pokomandy A, Rouleau D, Ghattas G, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: The HIPVIRG cohort study. J Infect Dis 2009; 199: 965-967.
15. Silva RJ, Casseb J, Andreoli MA, et al. Persistence and clearance of HPV from the penis of men infected and non-infected with HIV. J Med Virol 2011; 83: 127-131.
16. Videla S, Darwich L, Cañadas MP, et al. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1Yinfected women without history of cervical pathology. J Acquir Immune Defic Syndr 2009; 50: 168-175.
17. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138: 453-459.
18. Wilkin TJ, Palmer S, Brudney KF, et al. Anal intraepithelial neopla-sia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 2004; 190: 1685-1691.
19. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Age-specific prevalence and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: The HPV in men (HIM) study. J Infect Dis 2011; 203: 49-57.
20. Ogunbiyi OA, Scholefield JH, Raftery AT, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81: 365-367.
21. deSanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 1048-1056.
22. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on nonYAIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007; 165: 1143-1153.
23. Bower M, Palmieri C, Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 2006; 19: 14-19.
24. D'Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008; 48: 491-499.
25. Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22: 1203-1211.
26. Chaturvedi AK, Madeleine MM, Biggar RJ, et al. Risk of human papillomavirusYassociated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101: 1120-1130.
27. Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 2011; 377: 932-940.
28. Kreimer AR, Villa A, Nyitray AG, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prevent 2011; 20: 172-182.